Shinnihonseiyaku Co., Ltd.
新日本製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4931
FY2024 (Sep 2025) · J-GAAP · consolidated Source: filing S100XA5Q
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2024 (Sep 2025) runs Oct 1, 2024 – Sep 30, 2025.
| Gross margin | 80.0% |
|---|---|
| Operating margin | 11.6% |
| Net margin | 6.2% |
| Return on equity | 11.5%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 9.2% |
| Revenue growth (YoY) | 2.7% |
| EPS (basic) | ¥120.48 |
| EPS growth (YoY) | -7.1% |
| Current ratio | 4.94x |
| Equity ratio | 80.7% |
| Book value / share | ¥1,078.69 |
| Free cash flow | ¥4.5B |